InvestorsHub Logo
Followers 1
Posts 97
Boards Moderated 0
Alias Born 03/24/2009

Re: mkendra post# 4047

Tuesday, 11/05/2013 9:29:03 AM

Tuesday, November 05, 2013 9:29:03 AM

Post# of 8023
What are you talking about.........

ANN ARBOR, Mich., Oct. 31, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today reported that the company has regained compliance with the $1.00 minimum bid price requirement for continued listing under NASDAQ Listing Rule 5550(a)(2).

Read more: http://www.nasdaq.com/press-release/aastrom-biosciences-regains-compliance-with-nasdaq-minimum-bid-requirement-20131031-00822#ixzz2jmVilKzy
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News